Vote Scores
Filings read through

Joincare Pharmaceutical Group Industry Co., Ltd.: how funds voted at the meeting of 23 Sep 2024

Meeting
Season
year to 30 June 2025
Filers reporting
20
Ballot items
11

20 filers on Form N-PX reported votes at the Joincare Pharmaceutical Group Industry Co., Ltd. meeting of 23 Sep 2024. The records fall into 11 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Joincare Pharmaceutical Group Industry Co., Ltd. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: CAPITAL STRUCTURE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    32 vote records from 4 filers. 0 of the 4 filers that marked the item voted against management.

    • Positions of 4 fund families
    • For 4
  2. Item 2: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    9 vote records from 5 filers. 0 of the 5 filers that marked the item voted against management.

    • Positions of 4 fund families
    • For 3
    • Split or no vote 1
  3. Item 3: Approve Authorization of Board to Handle All Related Matters

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  4. Item 4: Approve Capital Source Used for the Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  5. Item 5: Approve Manner of Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  6. Item 6: Approve Period of the Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  7. Item 7: Approve Price Range and Pricing Principle of the Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  8. Item 8: Approve Purpose of Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  9. Item 9: Approve the Usage, Quantity, Proportion of the Company's Total Share Capital of the Repurchased Shares and...

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7
  10. Item 10: Approve Transfer of Land Use Right and Its Ground Building and Related to the Transfer of Raised Funds...

    23 vote records from 14 filers. 14 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • Against 7
    • Against management 7
  11. Item 11: Approve Type of Share Repurchase

    23 vote records from 14 filers. 0 of the 14 filers that marked the item voted against management.

    • Positions of 7 fund families
    • For 7

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Joincare Pharmaceutical Group Industry Co., Ltd., meeting of 23 Sep 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family3. Proposal4. Proposal5. Proposal6. Proposal7. Proposal8. Proposal9. Proposal10. Proposal
BNY MellonForForForForForForForAgainst, against management
DimensionalForForForForForForForAgainst, against management
Franklin TempletonForForForForForForForAgainst, against management
Northern Trust and FlexSharesForForForForForForForAgainst, against management
State Street and SPDRForForForForForForForAgainst, against management
VanguardForForForForForForForAgainst, against management
WisdomTreeForForForForForForForAgainst, against management

Questions

How many filers reported votes at the Joincare Pharmaceutical Group Industry Co., Ltd. meeting?
20 Form N-PX filers reported votes at the meeting of 23 Sep 2024. The filings show 9 separate proposals from security holders.
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Joincare Pharmaceutical Group Industry Co., Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Joincare Pharmaceutical Group Industry Co., Ltd. with a meeting date within three days of 23 Sep 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .